Drugs / High Dose Quadrivalent Inactivated Influenza Vaccine
High Dose Quadrivalent Inactivated Influenza Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05215327 | Nov 2022 → Jul 2027 expected | disease related to solid organ transplantation, influenza | Vanderbilt University Medical Center | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | High Dose Quadrivalent Inactivated Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05215327 ↗ |
| Modality | Vaccine | “Fluzone High-Dose (Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs.” NCT05215327 ↗ |
| Route | Intramuscular | “for intramuscular injection” NCT05215327 ↗ |